Partner Content: Highlights
Top videos
Events & Jobs
Upcoming events
Current jobs
Current CME continuing education
View Post

Current status of PAT

Psychedelic substances such as LSD, psilocybin and MDMA have increasingly become the focus of science and clinical practice in recent years. The substances are used as part of so-called psychedelic-assisted therapies (PAT), in which psychotherapeutic treatment is combined with the temporary administration of these substances. After research and clinical use largely came to a standstill in the 1970s, modern, controlled studies are now available that provide promising but not yet conclusive data on efficacy and safety…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Endometrial carcinoma

Endometrial carcinoma was long considered the “benign” type among gynecological malignancies: it presents with symptoms early, is usually diagnosed at Stage I, and is curable by surgery. This characterization remains true for the majority of patients. For the minority with advanced or recurrent disease, however, almost everything has changed within just a few years. Molecular classification has evolved from a research tool to the standard for treatment planning; the FIGO classification has incorporated molecular parameters into its staging system, and the combination of chemotherapy and checkpoint inhibition has produced survival curves in the mismatch repair-deficient subgroup that were previously unknown for this entity. Version 4 of the S3 guideline, published in May 2026 and…
View Post

Clinical Presentation, Diagnosis, and Treatment of DSPN

Distal symmetric sensorimotor polyneuropathy (DSPN) is the most common form of diabetic neuropathy. About one-third of all diabetes patients are affected by it. They often develop neuropathic pain, although a significant proportion remain completely symptom-free, at least at times—it is precisely these painless courses that are insidious, because they progress unnoticed toward a loss of sensation…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Why is it so hard to lose weight?

Obesity is the most common chronic disease in Western societies, with serious metabolic, cardiovascular, and psychosocial consequences. The therapeutic landscape has changed fundamentally: new-generation GLP-1 agonists achieve weight loss that, just a few years ago, was reserved solely for bariatric surgery. This presents physicians with a clear task: to understand obesity as a biologically based chronic disease and to treat it accordingly…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here